{"mainPropery":{"diseaseId":5732,"diseaseName":"Acute intermittent porphyria","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/5732/acute-intermittent-porphyria","synonyms":["AIP","Porphobilinogen deaminase deficiency","PBGD deficiency","Uroporphyrinogen synthase deficiency","UPS deficiency","Porphyria, Swedish type","Hydroxymethylbilane synthase deficiency","HMBS deficiency"],"synonyms-with-source":[{"name":"AIP"},{"name":"Porphobilinogen deaminase deficiency"},{"name":"PBGD deficiency"},{"name":"Uroporphyrinogen synthase deficiency"},{"name":"UPS deficiency"},{"name":"Porphyria, Swedish type"},{"name":"Hydroxymethylbilane synthase deficiency"},{"name":"HMBS deficiency"}],"identifiers":[{"identifierType":"OMIM","identifierId":"176000"},{"identifierType":"ORPHANET","identifierId":"79276"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases"},{"diseaseTypeId":26,"diseaseTypeName":"Kidney and Urinary Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"},{"diseaseTypeId":33,"diseaseTypeName":"RDCRN"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":69,"resourceName":" American Porphyria Foundation","abbreviation":"","address1":"4915 St. Elmo Avenue","address2":"Suite 105","address3":"","address4":"","address5":"","city":"Bethesda","state":"MD","zip":"20814","country":"United States","phone":"+1-301-347-7166","tty":"","tollFree":"1-866-273-3635","fax":"+1-301-312-8719","email":"porphyrus@porphyriafoundation.com","url":"https://porphyriafoundation.org/","freeText":""},{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""},{"resourceID":942,"resourceName":"American Association for the Study of Liver Diseases","abbreviation":"","address1":"1001 North Fairfax, 4th floor","address2":"","address3":"","address4":"","address5":"","city":"Alexandria","state":"VA","zip":"22314","country":"United States","phone":"703–299–9766","tty":"","tollFree":"","fax":"703–299–9622","email":"aasld@aasld.org","url":"http://www.aasld.org/","freeText":""},{"resourceID":943,"resourceName":"American Liver Foundation","abbreviation":"","address1":"39 Broadway, Suite 2700","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10006","country":"United States","phone":"+1-212-668-1000","tty":"","tollFree":"+1-800-465-4837 (Helpline)","fax":"","email":"https://liverfoundation.org/for-patients/contact-us/","url":"https://liverfoundation.org/","freeText":""},{"resourceID":3192,"resourceName":"European Porphyria Network","abbreviation":"EPNET","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"https://porphyria.eu/en/contact","url":"https://porphyria.eu/en","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/176000' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=176000' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Acute intermittent porphyria. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Acute+intermittent+porphyria%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Acute intermittent porphyria. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=porphyria' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Acute intermittent porphyria. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":336,"resourceId":1154,"resourceName":"RareConnect","descriptionText":"<div style=\"margin-top: 0px; margin-bottom: 0px;\"><a href='https://www.rareconnect.org/en/community/porphyria' target='_blank'>RareConnect</a> has an online community for patients&nbsp;and families with this condition so they can connect with others and share&nbsp;their experiences living with a rare disease.&nbsp;The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders).</div>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":876,"resourceId":1582,"resourceName":"RDCRN - Porphyrias Consortium","descriptionText":"The&nbsp;<a href='https://www.rarediseasesnetwork.org/cms/porphyrias/' target='_blank'>Porphyrias Consortium</a> is a team of doctors, nurses, research coordinators, and research labs throughout the U.S., working together to improve the lives of people with this condition&nbsp;through research. The&nbsp;Porphyrias Consortium has a registry for patients who wish to be contacted about clinical research opportunities. <br />\r\n<br />\r\nFor more information on the registry see:&nbsp;<a href='https://www.rarediseasesnetwork.org/cms/porphyrias/registry' target='_blank'>https://www.rarediseasesnetwork.org/cms/porphyrias/registry</a>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":1366,"resourceId":2017,"resourceName":"Porphyria Disease Management","descriptionText":"The American Porphyria Foundation offers a <a href='https://www.porphyriafoundation.org/for-patients/about-porphyria/' target='_blank'>document</a> that includes information about porphyria, types, testing, and treatment with <a href='https://porphyriafoundation.org/patients/about-porphyria/treatment-options' target='_blank'>Panhematin</a><sup>&#174;</sup>.  Click the \"document\" link above to view these guidelines.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0162565' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/318/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='https://www.nlm.nih.gov/medlineplus/ency/article/001208.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://www.emedicine.com/med/TOPIC1880.HTM' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79276' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=aip' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1549,"resourceId":2177,"resourceName":"National Human Genome Research Institute","descriptionText":"The <a href='http://www.genome.gov/19016728' target='_blank'>National Human Genome Research Institute's</a> (NHGRI) website has an information page on this topic. NHGRI is part of the National Institutes of Health and supports research on the structure and function of the human genome and its role in health and disease.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1702,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='https://www.orpha.net/data/patho/Pro/en/Emergency_AcuteHepaticPorphyria.pdf' target='_blank'>Orphanet Emergency Guidelines</a> is an article which is expert-authored and peer-reviewed that is intended to guide health care professionals in emergency situations involving this condition. &nbsp;","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:176000' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2161,"resourceId":3369,"resourceName":"HealthWell Foundation","descriptionText":"The <a href='http://www.healthwellfoundation.org/porphyrias' target='_blank'>HealthWell Foundation</a> provides financial assistance for underinsured patients living with chronic and life-altering conditions. They offer help with drug copayments, deductibles, and health insurance premiums for patients with specific diseases. The disease fund status can change over time, so you may need to check back if funds are not currently available.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":1148,"questionText":"What is acute intermittent porphyria (AIP)?","answerText":"<strong>Acute intermittent porphyria</strong> (AIP) is&nbsp;one of the&nbsp;liver (hepatic) <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001208.htm\" target=\"_blank\">porphyrias</a>. AIP is caused by low levels of porphobilinogen deaminase (PBGD), an <a href=\"http://www.genome.gov/glossary.cfm?key=enzyme\" target=\"_blank\">enzyme</a> also often called hydroxymethylbilane synthase. The low levels of PBGD are&nbsp;generally not sufficient to cause symptoms; however, activating factors such as hormones, drugs, and dietary changes may trigger symptoms. Although most individuals with AIP never develop symptoms,&nbsp;symptomatic individuals typically present with&nbsp;abdominal pain with nausea. Treatment is dependent on the symptoms.[690]&nbsp;","dateModified":"2015-11-11T00:00:00"},"basicQuestions":[{"questionId":1149,"questionText":"What are the signs and symptoms of acute intermittent porphyria (AIP)?","answerText":"Some people who inherit the gene for AIP never develop symptoms and are said to have \"latent\" AIP. Those individuals that present with symptoms&nbsp;usually do so&nbsp;after puberty, probably because of&nbsp;hormonal influences, although other activating factors include: alcohol, drugs (e.g., barbiturates, steroids, sulfa-containing antibiotics), chemicals, smoking, reduced caloric intake, stress, and travel. Symptoms usually last&nbsp;several days, but attacks for which treatment is not received promptly may last weeks or months.[691] <br />\r\n<br />\r\nAbdominal pain, which is associated with nausea and can be severe, is the most common symptom and usually the first sign of an attack.[690][691]<br />\r\n<br />\r\nOther symptoms may include [690][691]: <br />\r\n<br />\r\n&bull; Gastrointestinal issues (e.g., nausea, vomiting, constipation, diarrhea, <a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/003122.htm\" target=\"_blank\">abdominal distention</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000260.htm\" target=\"_blank\">ileus</a>)<br />\r\n&bull;&nbsp;Urinary tract&nbsp;issues (e.g., <a href=\"http://kidney.niddk.nih.gov/Kudiseases/pubs/UrinaryRetention/index.htm\" target=\"_blank\">urinary retention</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/urinaryincontinence.html\" target=\"_blank\">urinary incontinence</a>, or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003145.htm\" target=\"_blank\">dysuria</a>)<br />\r\n&bull; Neurological issues (e.g., muscle weakness in the arms or legs, <a href=\"http://www.nlm.nih.gov/medlineplus/paralysis.html\" target=\"_blank\">paralysis</a>)<br />\r\n&bull; Psychiatric&nbsp;issues (e.g., <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000805.htm\" target=\"_blank\">insomnia</a>, hysteria, anxiety, apathy or depression, phobias, psychosis, agitation, delirium, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003208.htm\" target=\"_blank\">somnolence</a>, or coma)<br />\r\n<br />\r\nIndividuals with AIP have an increased risk of developing <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000280.htm\" target=\"_blank\">hepatocellular carcinoma</a>; some develop kidney failure.[691]","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1150,"questionText":"What causes acute intermittent porphyria (AIP)?","answerText":"AIP is caused by the deficiency of an enzyme called porphobilinogen deaminase (PBGD), also known as hydroxymethylbilane synthase (HMBS) and&nbsp;formerly known as uroporphyrinogen I-synthase.[690] The deficiency of PBGD is caused by a mutation in the <em><a href=\"http://ghr.nlm.nih.gov/gene=hmbs\" tabindex=\"-1\" target=\"_blank\">HMBS</a></em> gene. The <em>HMBS</em> gene is the only gene known to be associated with AIP.[691] However, the deficiency of PBGD alone is not enough to cause AIP. Other activating factors (e.g., hormones, drugs, dietary changes) must also be present.[690]&nbsp;","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1151,"questionText":"How is acute intermittent porphyria (AIP) inherited?","answerText":"AIP is inherited in an <a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/002049.htm\" target=\"_blank\">autosomal dominant fashion</a>, which means only one of the two <em><a href=\"http://ghr.nlm.nih.gov/gene=hmbs\" target=\"_blank\">HMBS</a></em> <a href=\"http://www.genome.gov/glossary.cfm?key=gene\" target=\"_blank\">genes</a> needs to have a&nbsp;disease-causing <a href=\"http://www.genome.gov/glossary.cfm?key=mutation\" target=\"_blank\">mutation</a> to decrease <a href=\"http://www.genome.gov/glossary.cfm?key=enzyme\" target=\"_blank\">enzyme</a> activity and cause symptoms.[691]&nbsp;","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1830,"questionText":"How is acute intermittent porphyria (AIP) diagnosed?","answerText":"Diagnosis of AIP is suspected in individuals with otherwise unexplained severe, acute abdominal pain without physical signs.[691] The finding of increased levels of delta-aminolevulinic acid (ALA) and porphobilinogen (PBG) in urine establishes that one of the acute porphyrias is present. If PBGD is deficient in normal red blod cells, the diagnosis of AIP is established.[690] The diagnosis is confirmed in individuals with a <span class=\"ext-reflink\"><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/disease-causing-mutation/\" target=\"_blank\">disease-causing mutation</a></span> in the <em>HMBS</em> <span class=\"ext-reflink\"><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/gene/\" target=\"_blank\">gene</a></span>, the only <span class=\"ext-reflink\">gene</span> known to be associated with AIP, which encodes the erythrocyte hydroxymethylbilane synthase enzyme.&nbsp;<span class=\"ext-reflink\"><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/molecular-genetic-testing/\" target=\"_blank\">Molecular genetic testing</a></span> of the <em>HMBS</em> <span class=\"ext-reflink\">gene</span> detects more than 98% of <span class=\"ext-reflink\"><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/affected/\" target=\"_blank\">affected</a></span> individuals and is available in clinical laboratories.[691] To obtain a list of clinical laboratories offering genetic testing for AIP, <a href=\"http://www.ncbi.nlm.nih.gov/gtr/tests/?term=C0162565[DISCUI]&amp;test_type=Clinical&amp;display_string=Acute%20intermittent%20porphyria&amp;condition=C0162565\" tabindex=\"-1\" target=\"_blank\">click here</a>.","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1152,"questionText":"How might acute intermittent porphyria (AIP) be treated?","answerText":"Treatment of AIP may vary&nbsp;based on the trigger of the attack and the symptoms present. Treatment may include stopping medications that cause or worsen the symptoms, treating any infections which may be present, administration of pain medication, monitoring fluid balance and/or correcting electrolyte disturbances, monitoring neurologic status and administering respiratory support. Mild attacks can be manged with increased caloric intake and fluid replacement. Recurrent acute attacks should be managed by a porphyria specialist.[691] Hospitalization is often necessary.[690] &nbsp;<a href=\"http://www.porphyriafoundation.com/testing-and-treatment/medications-for-porphyria/panhematin\" tabindex=\"-1\" target=\"_blank\">Panhematin</a>, an intravenous medication used to correct heme deficiency,&nbsp;may also be prescribed.[1729] More detailed information about the use of Panhematin for the treatment of AIP can be found by <a href=\"http://www.porphyriafoundation.com/treatment\" tabindex=\"-1\" target=\"_blank\">clicking here</a>.","dateModified":"2015-11-11T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1729,"authors":"","articleTitle":"Treatment Options","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/treatment","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":10353,"relatedDiseaseName":"Porphyria","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":24879,"abbreviatedInquiry":"Can you provide me with general information about acute intermittent porphyria? How can I find a researcher or physician who is knowledgeable about this condition?","caseQuestions":[{"questionId":1148,"questionText":"What is acute intermittent porphyria (AIP)?","answerText":"<strong>Acute intermittent porphyria</strong> (AIP) is&nbsp;one of the&nbsp;liver (hepatic) <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001208.htm\" target=\"_blank\">porphyrias</a>. AIP is caused by low levels of porphobilinogen deaminase (PBGD), an <a href=\"http://www.genome.gov/glossary.cfm?key=enzyme\" target=\"_blank\">enzyme</a> also often called hydroxymethylbilane synthase. The low levels of PBGD are&nbsp;generally not sufficient to cause symptoms; however, activating factors such as hormones, drugs, and dietary changes may trigger symptoms. Although most individuals with AIP never develop symptoms,&nbsp;symptomatic individuals typically present with&nbsp;abdominal pain with nausea. Treatment is dependent on the symptoms.[690]&nbsp;","dateModified":"2015-11-11T00:00:00","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1149,"questionText":"What are the signs and symptoms of acute intermittent porphyria (AIP)?","answerText":"Some people who inherit the gene for AIP never develop symptoms and are said to have \"latent\" AIP. Those individuals that present with symptoms&nbsp;usually do so&nbsp;after puberty, probably because of&nbsp;hormonal influences, although other activating factors include: alcohol, drugs (e.g., barbiturates, steroids, sulfa-containing antibiotics), chemicals, smoking, reduced caloric intake, stress, and travel. Symptoms usually last&nbsp;several days, but attacks for which treatment is not received promptly may last weeks or months.[691] <br />\r\n<br />\r\nAbdominal pain, which is associated with nausea and can be severe, is the most common symptom and usually the first sign of an attack.[690][691]<br />\r\n<br />\r\nOther symptoms may include [690][691]: <br />\r\n<br />\r\n&bull; Gastrointestinal issues (e.g., nausea, vomiting, constipation, diarrhea, <a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/003122.htm\" target=\"_blank\">abdominal distention</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000260.htm\" target=\"_blank\">ileus</a>)<br />\r\n&bull;&nbsp;Urinary tract&nbsp;issues (e.g., <a href=\"http://kidney.niddk.nih.gov/Kudiseases/pubs/UrinaryRetention/index.htm\" target=\"_blank\">urinary retention</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/urinaryincontinence.html\" target=\"_blank\">urinary incontinence</a>, or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003145.htm\" target=\"_blank\">dysuria</a>)<br />\r\n&bull; Neurological issues (e.g., muscle weakness in the arms or legs, <a href=\"http://www.nlm.nih.gov/medlineplus/paralysis.html\" target=\"_blank\">paralysis</a>)<br />\r\n&bull; Psychiatric&nbsp;issues (e.g., <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000805.htm\" target=\"_blank\">insomnia</a>, hysteria, anxiety, apathy or depression, phobias, psychosis, agitation, delirium, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003208.htm\" target=\"_blank\">somnolence</a>, or coma)<br />\r\n<br />\r\nIndividuals with AIP have an increased risk of developing <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000280.htm\" target=\"_blank\">hepatocellular carcinoma</a>; some develop kidney failure.[691]","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1150,"questionText":"What causes acute intermittent porphyria (AIP)?","answerText":"AIP is caused by the deficiency of an enzyme called porphobilinogen deaminase (PBGD), also known as hydroxymethylbilane synthase (HMBS) and&nbsp;formerly known as uroporphyrinogen I-synthase.[690] The deficiency of PBGD is caused by a mutation in the <em><a href=\"http://ghr.nlm.nih.gov/gene=hmbs\" tabindex=\"-1\" target=\"_blank\">HMBS</a></em> gene. The <em>HMBS</em> gene is the only gene known to be associated with AIP.[691] However, the deficiency of PBGD alone is not enough to cause AIP. Other activating factors (e.g., hormones, drugs, dietary changes) must also be present.[690]&nbsp;","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1151,"questionText":"How is acute intermittent porphyria (AIP) inherited?","answerText":"AIP is inherited in an <a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/002049.htm\" target=\"_blank\">autosomal dominant fashion</a>, which means only one of the two <em><a href=\"http://ghr.nlm.nih.gov/gene=hmbs\" target=\"_blank\">HMBS</a></em> <a href=\"http://www.genome.gov/glossary.cfm?key=gene\" target=\"_blank\">genes</a> needs to have a&nbsp;disease-causing <a href=\"http://www.genome.gov/glossary.cfm?key=mutation\" target=\"_blank\">mutation</a> to decrease <a href=\"http://www.genome.gov/glossary.cfm?key=enzyme\" target=\"_blank\">enzyme</a> activity and cause symptoms.[691]&nbsp;","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1830,"questionText":"How is acute intermittent porphyria (AIP) diagnosed?","answerText":"Diagnosis of AIP is suspected in individuals with otherwise unexplained severe, acute abdominal pain without physical signs.[691] The finding of increased levels of delta-aminolevulinic acid (ALA) and porphobilinogen (PBG) in urine establishes that one of the acute porphyrias is present. If PBGD is deficient in normal red blod cells, the diagnosis of AIP is established.[690] The diagnosis is confirmed in individuals with a <span class=\"ext-reflink\"><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/disease-causing-mutation/\" target=\"_blank\">disease-causing mutation</a></span> in the <em>HMBS</em> <span class=\"ext-reflink\"><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/gene/\" target=\"_blank\">gene</a></span>, the only <span class=\"ext-reflink\">gene</span> known to be associated with AIP, which encodes the erythrocyte hydroxymethylbilane synthase enzyme.&nbsp;<span class=\"ext-reflink\"><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/molecular-genetic-testing/\" target=\"_blank\">Molecular genetic testing</a></span> of the <em>HMBS</em> <span class=\"ext-reflink\">gene</span> detects more than 98% of <span class=\"ext-reflink\"><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/affected/\" target=\"_blank\">affected</a></span> individuals and is available in clinical laboratories.[691] To obtain a list of clinical laboratories offering genetic testing for AIP, <a href=\"http://www.ncbi.nlm.nih.gov/gtr/tests/?term=C0162565[DISCUI]&amp;test_type=Clinical&amp;display_string=Acute%20intermittent%20porphyria&amp;condition=C0162565\" tabindex=\"-1\" target=\"_blank\">click here</a>.","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1152,"questionText":"How might acute intermittent porphyria (AIP) be treated?","answerText":"Treatment of AIP may vary&nbsp;based on the trigger of the attack and the symptoms present. Treatment may include stopping medications that cause or worsen the symptoms, treating any infections which may be present, administration of pain medication, monitoring fluid balance and/or correcting electrolyte disturbances, monitoring neurologic status and administering respiratory support. Mild attacks can be manged with increased caloric intake and fluid replacement. Recurrent acute attacks should be managed by a porphyria specialist.[691] Hospitalization is often necessary.[690] &nbsp;<a href=\"http://www.porphyriafoundation.com/testing-and-treatment/medications-for-porphyria/panhematin\" tabindex=\"-1\" target=\"_blank\">Panhematin</a>, an intravenous medication used to correct heme deficiency,&nbsp;may also be prescribed.[1729] More detailed information about the use of Panhematin for the treatment of AIP can be found by <a href=\"http://www.porphyriafoundation.com/treatment\" tabindex=\"-1\" target=\"_blank\">clicking here</a>.","dateModified":"2015-11-11T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1729,"authors":"","articleTitle":"Treatment Options","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/treatment","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2669,"questionText":"How can I find a physician or researcher who is knowledgeable about acute intermittent porphyria?","answerText":"Because porphyria is so rare, few physicians have experience treating patients with the disease.&nbsp;The American Porphyria Foundation (APF) can help individuals with porphyria by putting&nbsp;their doctor's office in touch with a porphyria specialist who can offer guidance on&nbsp;their care. Clinicians and researchers specializing in porphyria are available to consult on suspected or confirmed cases of porphyria, and to discuss the individual course of treatment. Some specialists can assist with diagnostic testing, and some are available for clinical consultation with patients. There is one telemedicine facility for porphyria consultation in the country, at the University of Texas-Medical branch, in Galveston.&nbsp;Patients and physicians interested in utilizing the services mentioned above may call the APF office at 713-266-9617 for information on contacting the specialist who can best address&nbsp;their concerns. More information about this service can be accessed by <a href=\"http://www.porphyriafoundation.com/for-healthcare-professionals\" target=\"_blank\">clicking here</a>.&nbsp;<br />\r\n<br />\r\nAdditional researchers and physicians can be found through the Porphyrias Consortium.&nbsp;This  resource includes five of the leading porphyria centers in the United States that provide expertise and experience in the diagnosis and treatment of patients with porphyria. The staff in each Center includes porphyria physicians, researchers, research coordinators, and technical/laboratory staff. Together with the American Porphyria Foundation, the Porphyrias Consortium enables a large scale collaborative effort to develop new strategies and methods for diagnosis, treatment, and prevention of illness and disability resulting from these rare disorders. For more information about the Porphyrias Consortium,&nbsp;<a href=\"http://www.rarediseasesnetwork.org/porphyrias/\" target=\"_blank\">click here</a>.","dateModified":"2015-11-11T00:00:00","references":[]}]},{"caseId":24493,"abbreviatedInquiry":"My child may be at risk to develop acute intermittent porphyria due to a history of the disease on his father's side of the family. Is it possible for an individual with the mutation causing this condition to be asymptomatic? How old must one be in order to be tested? ","caseQuestions":[{"questionId":1148,"questionText":"What is acute intermittent porphyria (AIP)?","answerText":"<strong>Acute intermittent porphyria</strong> (AIP) is&nbsp;one of the&nbsp;liver (hepatic) <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001208.htm\" target=\"_blank\">porphyrias</a>. AIP is caused by low levels of porphobilinogen deaminase (PBGD), an <a href=\"http://www.genome.gov/glossary.cfm?key=enzyme\" target=\"_blank\">enzyme</a> also often called hydroxymethylbilane synthase. The low levels of PBGD are&nbsp;generally not sufficient to cause symptoms; however, activating factors such as hormones, drugs, and dietary changes may trigger symptoms. Although most individuals with AIP never develop symptoms,&nbsp;symptomatic individuals typically present with&nbsp;abdominal pain with nausea. Treatment is dependent on the symptoms.[690]&nbsp;","dateModified":"2015-11-11T00:00:00","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1149,"questionText":"What are the signs and symptoms of acute intermittent porphyria (AIP)?","answerText":"Some people who inherit the gene for AIP never develop symptoms and are said to have \"latent\" AIP. Those individuals that present with symptoms&nbsp;usually do so&nbsp;after puberty, probably because of&nbsp;hormonal influences, although other activating factors include: alcohol, drugs (e.g., barbiturates, steroids, sulfa-containing antibiotics), chemicals, smoking, reduced caloric intake, stress, and travel. Symptoms usually last&nbsp;several days, but attacks for which treatment is not received promptly may last weeks or months.[691] <br />\r\n<br />\r\nAbdominal pain, which is associated with nausea and can be severe, is the most common symptom and usually the first sign of an attack.[690][691]<br />\r\n<br />\r\nOther symptoms may include [690][691]: <br />\r\n<br />\r\n&bull; Gastrointestinal issues (e.g., nausea, vomiting, constipation, diarrhea, <a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/003122.htm\" target=\"_blank\">abdominal distention</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000260.htm\" target=\"_blank\">ileus</a>)<br />\r\n&bull;&nbsp;Urinary tract&nbsp;issues (e.g., <a href=\"http://kidney.niddk.nih.gov/Kudiseases/pubs/UrinaryRetention/index.htm\" target=\"_blank\">urinary retention</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/urinaryincontinence.html\" target=\"_blank\">urinary incontinence</a>, or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003145.htm\" target=\"_blank\">dysuria</a>)<br />\r\n&bull; Neurological issues (e.g., muscle weakness in the arms or legs, <a href=\"http://www.nlm.nih.gov/medlineplus/paralysis.html\" target=\"_blank\">paralysis</a>)<br />\r\n&bull; Psychiatric&nbsp;issues (e.g., <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000805.htm\" target=\"_blank\">insomnia</a>, hysteria, anxiety, apathy or depression, phobias, psychosis, agitation, delirium, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003208.htm\" target=\"_blank\">somnolence</a>, or coma)<br />\r\n<br />\r\nIndividuals with AIP have an increased risk of developing <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000280.htm\" target=\"_blank\">hepatocellular carcinoma</a>; some develop kidney failure.[691]","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2556,"questionText":"Is it possible for an individual who has the disease-causing mutation for acute intermittent porphyria (AIP) to remain asymptomatic?","answerText":"Some people who inherit the gene for&nbsp;AIP&nbsp;never develop symptoms and are said to have \"latent\" AIP.[691]","dateModified":"2015-11-12T00:00:00","references":[{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1150,"questionText":"What causes acute intermittent porphyria (AIP)?","answerText":"AIP is caused by the deficiency of an enzyme called porphobilinogen deaminase (PBGD), also known as hydroxymethylbilane synthase (HMBS) and&nbsp;formerly known as uroporphyrinogen I-synthase.[690] The deficiency of PBGD is caused by a mutation in the <em><a href=\"http://ghr.nlm.nih.gov/gene=hmbs\" tabindex=\"-1\" target=\"_blank\">HMBS</a></em> gene. The <em>HMBS</em> gene is the only gene known to be associated with AIP.[691] However, the deficiency of PBGD alone is not enough to cause AIP. Other activating factors (e.g., hormones, drugs, dietary changes) must also be present.[690]&nbsp;","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1151,"questionText":"How is acute intermittent porphyria (AIP) inherited?","answerText":"AIP is inherited in an <a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/002049.htm\" target=\"_blank\">autosomal dominant fashion</a>, which means only one of the two <em><a href=\"http://ghr.nlm.nih.gov/gene=hmbs\" target=\"_blank\">HMBS</a></em> <a href=\"http://www.genome.gov/glossary.cfm?key=gene\" target=\"_blank\">genes</a> needs to have a&nbsp;disease-causing <a href=\"http://www.genome.gov/glossary.cfm?key=mutation\" target=\"_blank\">mutation</a> to decrease <a href=\"http://www.genome.gov/glossary.cfm?key=enzyme\" target=\"_blank\">enzyme</a> activity and cause symptoms.[691]&nbsp;","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2558,"questionText":"Can asymptomatic individuals be tested for acute intermittent porphyria (AIP)?","answerText":"Testing of at-risk asymptomatic adults for AIP is available using either assay of erythrocyte HMBS enzyme activity or, if the <span class=\"ext-reflink\">mutation</span> is known in an <span class=\"ext-reflink\">affected</span> family member, <span class=\"ext-reflink\">molecular genetic testing</span> of the <em>HMBS</em> <span class=\"ext-reflink\">gene</span>. Such testing is not useful in predicting&nbsp;whether individuals who inherit an <em>HMBS</em> <span class=\"ext-reflink\">mutation</span> will be symptomatic, or if they are, the age of onset, severity, or type of symptoms.&nbsp;Before testing at-risk individuals for AIP, it is necessary to first test an <span class=\"ext-reflink\">affected</span> family member to confirm that the disorder in the family is actually AIP.[691] <br />\r\n<br />\r\n<span class=\"ext-reflink\">Molecular genetic testing</span> of the <em>HMBS</em> <span class=\"ext-reflink\">gene</span> detects more than 98% of <span class=\"ext-reflink\">affected</span> individuals and is available in clinical laboratories.[691] To obtain a list of clinical laboratories offering genetic testing for AIP, <a href=\"http://www.ncbi.nlm.nih.gov/gtr/tests/?term=C0162565%5BDISCUI%5D&amp;condition=C0162565&amp;compare_labs=1\" target=\"_blank\">click here</a>. <br />\r\n<br />\r\n<br />","dateModified":"2015-11-12T00:00:00","references":[{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2557,"questionText":"How old must one be in order to be tested for acute intermittent porphyria (AIP)?","answerText":"Although most testing is done in adults, there may be an advantage to testing at-risk asymptomatic individuals prior to puberty, as&nbsp;symptoms&nbsp;most often develop&nbsp;after this age.&nbsp;Identification of individuals at risk for AIP may&nbsp;alter management because avoidance of known risk factors may be helpful in preventing acute attacks and afford prompt treatment should an attack occur.[691]&nbsp;<br />","dateModified":"2015-11-12T00:00:00","references":[{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":23945,"abbreviatedInquiry":"I was recently diagnosed with acute intermittent porphyria. I would like to learn more about this condition. I was also informed some time ago that the porphyrias can be disabling. What information can you provide?","caseQuestions":[{"questionId":1148,"questionText":"What is acute intermittent porphyria (AIP)?","answerText":"<strong>Acute intermittent porphyria</strong> (AIP) is&nbsp;one of the&nbsp;liver (hepatic) <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001208.htm\" target=\"_blank\">porphyrias</a>. AIP is caused by low levels of porphobilinogen deaminase (PBGD), an <a href=\"http://www.genome.gov/glossary.cfm?key=enzyme\" target=\"_blank\">enzyme</a> also often called hydroxymethylbilane synthase. The low levels of PBGD are&nbsp;generally not sufficient to cause symptoms; however, activating factors such as hormones, drugs, and dietary changes may trigger symptoms. Although most individuals with AIP never develop symptoms,&nbsp;symptomatic individuals typically present with&nbsp;abdominal pain with nausea. Treatment is dependent on the symptoms.[690]&nbsp;","dateModified":"2015-11-11T00:00:00","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1149,"questionText":"What are the signs and symptoms of acute intermittent porphyria (AIP)?","answerText":"Some people who inherit the gene for AIP never develop symptoms and are said to have \"latent\" AIP. Those individuals that present with symptoms&nbsp;usually do so&nbsp;after puberty, probably because of&nbsp;hormonal influences, although other activating factors include: alcohol, drugs (e.g., barbiturates, steroids, sulfa-containing antibiotics), chemicals, smoking, reduced caloric intake, stress, and travel. Symptoms usually last&nbsp;several days, but attacks for which treatment is not received promptly may last weeks or months.[691] <br />\r\n<br />\r\nAbdominal pain, which is associated with nausea and can be severe, is the most common symptom and usually the first sign of an attack.[690][691]<br />\r\n<br />\r\nOther symptoms may include [690][691]: <br />\r\n<br />\r\n&bull; Gastrointestinal issues (e.g., nausea, vomiting, constipation, diarrhea, <a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/003122.htm\" target=\"_blank\">abdominal distention</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000260.htm\" target=\"_blank\">ileus</a>)<br />\r\n&bull;&nbsp;Urinary tract&nbsp;issues (e.g., <a href=\"http://kidney.niddk.nih.gov/Kudiseases/pubs/UrinaryRetention/index.htm\" target=\"_blank\">urinary retention</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/urinaryincontinence.html\" target=\"_blank\">urinary incontinence</a>, or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003145.htm\" target=\"_blank\">dysuria</a>)<br />\r\n&bull; Neurological issues (e.g., muscle weakness in the arms or legs, <a href=\"http://www.nlm.nih.gov/medlineplus/paralysis.html\" target=\"_blank\">paralysis</a>)<br />\r\n&bull; Psychiatric&nbsp;issues (e.g., <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000805.htm\" target=\"_blank\">insomnia</a>, hysteria, anxiety, apathy or depression, phobias, psychosis, agitation, delirium, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003208.htm\" target=\"_blank\">somnolence</a>, or coma)<br />\r\n<br />\r\nIndividuals with AIP have an increased risk of developing <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000280.htm\" target=\"_blank\">hepatocellular carcinoma</a>; some develop kidney failure.[691]","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1150,"questionText":"What causes acute intermittent porphyria (AIP)?","answerText":"AIP is caused by the deficiency of an enzyme called porphobilinogen deaminase (PBGD), also known as hydroxymethylbilane synthase (HMBS) and&nbsp;formerly known as uroporphyrinogen I-synthase.[690] The deficiency of PBGD is caused by a mutation in the <em><a href=\"http://ghr.nlm.nih.gov/gene=hmbs\" tabindex=\"-1\" target=\"_blank\">HMBS</a></em> gene. The <em>HMBS</em> gene is the only gene known to be associated with AIP.[691] However, the deficiency of PBGD alone is not enough to cause AIP. Other activating factors (e.g., hormones, drugs, dietary changes) must also be present.[690]&nbsp;","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1151,"questionText":"How is acute intermittent porphyria (AIP) inherited?","answerText":"AIP is inherited in an <a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/002049.htm\" target=\"_blank\">autosomal dominant fashion</a>, which means only one of the two <em><a href=\"http://ghr.nlm.nih.gov/gene=hmbs\" target=\"_blank\">HMBS</a></em> <a href=\"http://www.genome.gov/glossary.cfm?key=gene\" target=\"_blank\">genes</a> needs to have a&nbsp;disease-causing <a href=\"http://www.genome.gov/glossary.cfm?key=mutation\" target=\"_blank\">mutation</a> to decrease <a href=\"http://www.genome.gov/glossary.cfm?key=enzyme\" target=\"_blank\">enzyme</a> activity and cause symptoms.[691]&nbsp;","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1830,"questionText":"How is acute intermittent porphyria (AIP) diagnosed?","answerText":"Diagnosis of AIP is suspected in individuals with otherwise unexplained severe, acute abdominal pain without physical signs.[691] The finding of increased levels of delta-aminolevulinic acid (ALA) and porphobilinogen (PBG) in urine establishes that one of the acute porphyrias is present. If PBGD is deficient in normal red blod cells, the diagnosis of AIP is established.[690] The diagnosis is confirmed in individuals with a <span class=\"ext-reflink\"><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/disease-causing-mutation/\" target=\"_blank\">disease-causing mutation</a></span> in the <em>HMBS</em> <span class=\"ext-reflink\"><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/gene/\" target=\"_blank\">gene</a></span>, the only <span class=\"ext-reflink\">gene</span> known to be associated with AIP, which encodes the erythrocyte hydroxymethylbilane synthase enzyme.&nbsp;<span class=\"ext-reflink\"><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/molecular-genetic-testing/\" target=\"_blank\">Molecular genetic testing</a></span> of the <em>HMBS</em> <span class=\"ext-reflink\">gene</span> detects more than 98% of <span class=\"ext-reflink\"><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/affected/\" target=\"_blank\">affected</a></span> individuals and is available in clinical laboratories.[691] To obtain a list of clinical laboratories offering genetic testing for AIP, <a href=\"http://www.ncbi.nlm.nih.gov/gtr/tests/?term=C0162565[DISCUI]&amp;test_type=Clinical&amp;display_string=Acute%20intermittent%20porphyria&amp;condition=C0162565\" tabindex=\"-1\" target=\"_blank\">click here</a>.","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1152,"questionText":"How might acute intermittent porphyria (AIP) be treated?","answerText":"Treatment of AIP may vary&nbsp;based on the trigger of the attack and the symptoms present. Treatment may include stopping medications that cause or worsen the symptoms, treating any infections which may be present, administration of pain medication, monitoring fluid balance and/or correcting electrolyte disturbances, monitoring neurologic status and administering respiratory support. Mild attacks can be manged with increased caloric intake and fluid replacement. Recurrent acute attacks should be managed by a porphyria specialist.[691] Hospitalization is often necessary.[690] &nbsp;<a href=\"http://www.porphyriafoundation.com/testing-and-treatment/medications-for-porphyria/panhematin\" tabindex=\"-1\" target=\"_blank\">Panhematin</a>, an intravenous medication used to correct heme deficiency,&nbsp;may also be prescribed.[1729] More detailed information about the use of Panhematin for the treatment of AIP can be found by <a href=\"http://www.porphyriafoundation.com/treatment\" tabindex=\"-1\" target=\"_blank\">clicking here</a>.","dateModified":"2015-11-11T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1729,"authors":"","articleTitle":"Treatment Options","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/treatment","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2082,"questionText":"Can acute intermittent porphyria (AIP) be disabling?","answerText":"Acute intermittent porphyria can be severe and debilitating. During an acute attack, AIP may affect the visceral (internal organ), <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/8679.htm\" target=\"_blank\">peripheral</a> (affecting the peripheral nerves - nerves to the hands and feet), <a href=\"http://www.merckmanuals.com/home/brain-spinal-cord-and-nerve-disorders/autonomic-nervous-system-disorders/overview-of-the-autonomic-nervous-system\" target=\"_blank\">autonomic</a>, and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/8679.htm\" target=\"_blank\">central</a> (brain and spinal cord) nervous systems, leading to a wide variety of symptoms which are usually intermittent and can be life-threatening. The course of an acute attack is highly variable within an individual as well as among individuals. Affected individuals may recover from acute attacks within days, but recovery from severe attacks that are not&nbsp;promptly recognized and treated may take weeks or months.[691]&nbsp;","dateModified":"2015-11-12T00:00:00","references":[{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":23562,"abbreviatedInquiry":"My daughter may have acute intermittent porphyria. How is this condition diagnosed? ","caseQuestions":[{"questionId":1148,"questionText":"What is acute intermittent porphyria (AIP)?","answerText":"<strong>Acute intermittent porphyria</strong> (AIP) is&nbsp;one of the&nbsp;liver (hepatic) <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001208.htm\" target=\"_blank\">porphyrias</a>. AIP is caused by low levels of porphobilinogen deaminase (PBGD), an <a href=\"http://www.genome.gov/glossary.cfm?key=enzyme\" target=\"_blank\">enzyme</a> also often called hydroxymethylbilane synthase. The low levels of PBGD are&nbsp;generally not sufficient to cause symptoms; however, activating factors such as hormones, drugs, and dietary changes may trigger symptoms. Although most individuals with AIP never develop symptoms,&nbsp;symptomatic individuals typically present with&nbsp;abdominal pain with nausea. Treatment is dependent on the symptoms.[690]&nbsp;","dateModified":"2015-11-11T00:00:00","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1149,"questionText":"What are the signs and symptoms of acute intermittent porphyria (AIP)?","answerText":"Some people who inherit the gene for AIP never develop symptoms and are said to have \"latent\" AIP. Those individuals that present with symptoms&nbsp;usually do so&nbsp;after puberty, probably because of&nbsp;hormonal influences, although other activating factors include: alcohol, drugs (e.g., barbiturates, steroids, sulfa-containing antibiotics), chemicals, smoking, reduced caloric intake, stress, and travel. Symptoms usually last&nbsp;several days, but attacks for which treatment is not received promptly may last weeks or months.[691] <br />\r\n<br />\r\nAbdominal pain, which is associated with nausea and can be severe, is the most common symptom and usually the first sign of an attack.[690][691]<br />\r\n<br />\r\nOther symptoms may include [690][691]: <br />\r\n<br />\r\n&bull; Gastrointestinal issues (e.g., nausea, vomiting, constipation, diarrhea, <a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/003122.htm\" target=\"_blank\">abdominal distention</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000260.htm\" target=\"_blank\">ileus</a>)<br />\r\n&bull;&nbsp;Urinary tract&nbsp;issues (e.g., <a href=\"http://kidney.niddk.nih.gov/Kudiseases/pubs/UrinaryRetention/index.htm\" target=\"_blank\">urinary retention</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/urinaryincontinence.html\" target=\"_blank\">urinary incontinence</a>, or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003145.htm\" target=\"_blank\">dysuria</a>)<br />\r\n&bull; Neurological issues (e.g., muscle weakness in the arms or legs, <a href=\"http://www.nlm.nih.gov/medlineplus/paralysis.html\" target=\"_blank\">paralysis</a>)<br />\r\n&bull; Psychiatric&nbsp;issues (e.g., <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000805.htm\" target=\"_blank\">insomnia</a>, hysteria, anxiety, apathy or depression, phobias, psychosis, agitation, delirium, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003208.htm\" target=\"_blank\">somnolence</a>, or coma)<br />\r\n<br />\r\nIndividuals with AIP have an increased risk of developing <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000280.htm\" target=\"_blank\">hepatocellular carcinoma</a>; some develop kidney failure.[691]","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1150,"questionText":"What causes acute intermittent porphyria (AIP)?","answerText":"AIP is caused by the deficiency of an enzyme called porphobilinogen deaminase (PBGD), also known as hydroxymethylbilane synthase (HMBS) and&nbsp;formerly known as uroporphyrinogen I-synthase.[690] The deficiency of PBGD is caused by a mutation in the <em><a href=\"http://ghr.nlm.nih.gov/gene=hmbs\" tabindex=\"-1\" target=\"_blank\">HMBS</a></em> gene. The <em>HMBS</em> gene is the only gene known to be associated with AIP.[691] However, the deficiency of PBGD alone is not enough to cause AIP. Other activating factors (e.g., hormones, drugs, dietary changes) must also be present.[690]&nbsp;","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1830,"questionText":"How is acute intermittent porphyria (AIP) diagnosed?","answerText":"Diagnosis of AIP is suspected in individuals with otherwise unexplained severe, acute abdominal pain without physical signs.[691] The finding of increased levels of delta-aminolevulinic acid (ALA) and porphobilinogen (PBG) in urine establishes that one of the acute porphyrias is present. If PBGD is deficient in normal red blod cells, the diagnosis of AIP is established.[690] The diagnosis is confirmed in individuals with a <span class=\"ext-reflink\"><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/disease-causing-mutation/\" target=\"_blank\">disease-causing mutation</a></span> in the <em>HMBS</em> <span class=\"ext-reflink\"><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/gene/\" target=\"_blank\">gene</a></span>, the only <span class=\"ext-reflink\">gene</span> known to be associated with AIP, which encodes the erythrocyte hydroxymethylbilane synthase enzyme.&nbsp;<span class=\"ext-reflink\"><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/molecular-genetic-testing/\" target=\"_blank\">Molecular genetic testing</a></span> of the <em>HMBS</em> <span class=\"ext-reflink\">gene</span> detects more than 98% of <span class=\"ext-reflink\"><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK5191/def-item/affected/\" target=\"_blank\">affected</a></span> individuals and is available in clinical laboratories.[691] To obtain a list of clinical laboratories offering genetic testing for AIP, <a href=\"http://www.ncbi.nlm.nih.gov/gtr/tests/?term=C0162565[DISCUI]&amp;test_type=Clinical&amp;display_string=Acute%20intermittent%20porphyria&amp;condition=C0162565\" tabindex=\"-1\" target=\"_blank\">click here</a>.","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1152,"questionText":"How might acute intermittent porphyria (AIP) be treated?","answerText":"Treatment of AIP may vary&nbsp;based on the trigger of the attack and the symptoms present. Treatment may include stopping medications that cause or worsen the symptoms, treating any infections which may be present, administration of pain medication, monitoring fluid balance and/or correcting electrolyte disturbances, monitoring neurologic status and administering respiratory support. Mild attacks can be manged with increased caloric intake and fluid replacement. Recurrent acute attacks should be managed by a porphyria specialist.[691] Hospitalization is often necessary.[690] &nbsp;<a href=\"http://www.porphyriafoundation.com/testing-and-treatment/medications-for-porphyria/panhematin\" tabindex=\"-1\" target=\"_blank\">Panhematin</a>, an intravenous medication used to correct heme deficiency,&nbsp;may also be prescribed.[1729] More detailed information about the use of Panhematin for the treatment of AIP can be found by <a href=\"http://www.porphyriafoundation.com/treatment\" tabindex=\"-1\" target=\"_blank\">clicking here</a>.","dateModified":"2015-11-11T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1729,"authors":"","articleTitle":"Treatment Options","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/treatment","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":17992,"abbreviatedInquiry":"What can you tell me about acute intermittent porphyria and Chester porphyria?","caseQuestions":[{"questionId":1148,"questionText":"What is acute intermittent porphyria (AIP)?","answerText":"<strong>Acute intermittent porphyria</strong> (AIP) is&nbsp;one of the&nbsp;liver (hepatic) <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001208.htm\" target=\"_blank\">porphyrias</a>. AIP is caused by low levels of porphobilinogen deaminase (PBGD), an <a href=\"http://www.genome.gov/glossary.cfm?key=enzyme\" target=\"_blank\">enzyme</a> also often called hydroxymethylbilane synthase. The low levels of PBGD are&nbsp;generally not sufficient to cause symptoms; however, activating factors such as hormones, drugs, and dietary changes may trigger symptoms. Although most individuals with AIP never develop symptoms,&nbsp;symptomatic individuals typically present with&nbsp;abdominal pain with nausea. Treatment is dependent on the symptoms.[690]&nbsp;","dateModified":"2015-11-11T00:00:00","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1149,"questionText":"What are the signs and symptoms of acute intermittent porphyria (AIP)?","answerText":"Some people who inherit the gene for AIP never develop symptoms and are said to have \"latent\" AIP. Those individuals that present with symptoms&nbsp;usually do so&nbsp;after puberty, probably because of&nbsp;hormonal influences, although other activating factors include: alcohol, drugs (e.g., barbiturates, steroids, sulfa-containing antibiotics), chemicals, smoking, reduced caloric intake, stress, and travel. Symptoms usually last&nbsp;several days, but attacks for which treatment is not received promptly may last weeks or months.[691] <br />\r\n<br />\r\nAbdominal pain, which is associated with nausea and can be severe, is the most common symptom and usually the first sign of an attack.[690][691]<br />\r\n<br />\r\nOther symptoms may include [690][691]: <br />\r\n<br />\r\n&bull; Gastrointestinal issues (e.g., nausea, vomiting, constipation, diarrhea, <a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/003122.htm\" target=\"_blank\">abdominal distention</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000260.htm\" target=\"_blank\">ileus</a>)<br />\r\n&bull;&nbsp;Urinary tract&nbsp;issues (e.g., <a href=\"http://kidney.niddk.nih.gov/Kudiseases/pubs/UrinaryRetention/index.htm\" target=\"_blank\">urinary retention</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/urinaryincontinence.html\" target=\"_blank\">urinary incontinence</a>, or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003145.htm\" target=\"_blank\">dysuria</a>)<br />\r\n&bull; Neurological issues (e.g., muscle weakness in the arms or legs, <a href=\"http://www.nlm.nih.gov/medlineplus/paralysis.html\" target=\"_blank\">paralysis</a>)<br />\r\n&bull; Psychiatric&nbsp;issues (e.g., <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000805.htm\" target=\"_blank\">insomnia</a>, hysteria, anxiety, apathy or depression, phobias, psychosis, agitation, delirium, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003208.htm\" target=\"_blank\">somnolence</a>, or coma)<br />\r\n<br />\r\nIndividuals with AIP have an increased risk of developing <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000280.htm\" target=\"_blank\">hepatocellular carcinoma</a>; some develop kidney failure.[691]","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1150,"questionText":"What causes acute intermittent porphyria (AIP)?","answerText":"AIP is caused by the deficiency of an enzyme called porphobilinogen deaminase (PBGD), also known as hydroxymethylbilane synthase (HMBS) and&nbsp;formerly known as uroporphyrinogen I-synthase.[690] The deficiency of PBGD is caused by a mutation in the <em><a href=\"http://ghr.nlm.nih.gov/gene=hmbs\" tabindex=\"-1\" target=\"_blank\">HMBS</a></em> gene. The <em>HMBS</em> gene is the only gene known to be associated with AIP.[691] However, the deficiency of PBGD alone is not enough to cause AIP. Other activating factors (e.g., hormones, drugs, dietary changes) must also be present.[690]&nbsp;","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1151,"questionText":"How is acute intermittent porphyria (AIP) inherited?","answerText":"AIP is inherited in an <a href=\"http://www.nlm.nih.gov/MEDLINEPLUS/ency/article/002049.htm\" target=\"_blank\">autosomal dominant fashion</a>, which means only one of the two <em><a href=\"http://ghr.nlm.nih.gov/gene=hmbs\" target=\"_blank\">HMBS</a></em> <a href=\"http://www.genome.gov/glossary.cfm?key=gene\" target=\"_blank\">genes</a> needs to have a&nbsp;disease-causing <a href=\"http://www.genome.gov/glossary.cfm?key=mutation\" target=\"_blank\">mutation</a> to decrease <a href=\"http://www.genome.gov/glossary.cfm?key=enzyme\" target=\"_blank\">enzyme</a> activity and cause symptoms.[691]&nbsp;","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1152,"questionText":"How might acute intermittent porphyria (AIP) be treated?","answerText":"Treatment of AIP may vary&nbsp;based on the trigger of the attack and the symptoms present. Treatment may include stopping medications that cause or worsen the symptoms, treating any infections which may be present, administration of pain medication, monitoring fluid balance and/or correcting electrolyte disturbances, monitoring neurologic status and administering respiratory support. Mild attacks can be manged with increased caloric intake and fluid replacement. Recurrent acute attacks should be managed by a porphyria specialist.[691] Hospitalization is often necessary.[690] &nbsp;<a href=\"http://www.porphyriafoundation.com/testing-and-treatment/medications-for-porphyria/panhematin\" tabindex=\"-1\" target=\"_blank\">Panhematin</a>, an intravenous medication used to correct heme deficiency,&nbsp;may also be prescribed.[1729] More detailed information about the use of Panhematin for the treatment of AIP can be found by <a href=\"http://www.porphyriafoundation.com/treatment\" tabindex=\"-1\" target=\"_blank\">clicking here</a>.","dateModified":"2015-11-11T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":690,"authors":"","articleTitle":"Acute Intermittent Porphyria (AIP)","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":691,"authors":"Whatley SD, Badminton MN","articleTitle":"Acute Intermittent Porphyria","bookWebsiteJournalTitle":"GeneReviews","date":"February 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1193/","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1729,"authors":"","articleTitle":"Treatment Options","bookWebsiteJournalTitle":"American Porphyria Foundation","date":"2015","volume":"","pages":"","url":"http://www.porphyriafoundation.com/treatment","dateAccessed":"2015-11-11T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1153,"questionText":"What is Chester porphyria?","answerText":"<strong>Chester porphyria</strong> is a unique type of porphyria with the signs and symptoms of <a href=\"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/AIP\" target=\"_blank\">acute intermittent porphyria (AIP)</a> and the biochemical defects of both AIP and <a href=\"http://www.porphyriafoundation.com/about-porphyria/types-of-porphyria/VP\" target=\"_blank\">variegate porphyria (VP)</a>.&nbsp; Chester porphyria does not conform to any of the recognized types of <a href=\"http://www.emedicine.com/ped/topic1870.htm\" target=\"_blank\">acute porphyria</a>. The symptoms associated with Chester porphyria are similar to those observed in other acute porphyrias. Treatment is symptomatic.[692]","dateModified":"2015-11-12T00:00:00","references":[{"referenceId":692,"authors":"Koyamangalath K","articleTitle":"","bookWebsiteJournalTitle":"Medscape Reference","date":"April 28, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/205314-overview","dateAccessed":"2015-11-12T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1154,"questionText":"What are the symptoms of Chester porphyria?","answerText":"Chester porphyria causes the same symptoms&nbsp;common to all <a href=\"http://emedicine.medscape.com/article/957604-clinical#showall\" target=\"_blank\">acute porphyrias</a>. Unlike in variegate porphyrias,&nbsp;skin sensitivity to light is not a feature of Chester porphyria.[692]&nbsp; To view a list of symptoms seen in Chester porphyria, <a href=\"http://emedicine.medscape.com/article/205314-clinical#showall\" target=\"_blank\">click here</a>.","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":692,"authors":"Koyamangalath K","articleTitle":"","bookWebsiteJournalTitle":"Medscape Reference","date":"April 28, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/205314-overview","dateAccessed":"2015-11-12T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1155,"questionText":"What causes Chester porphyria?","answerText":"Genetic studies have&nbsp;linked Chester porphyria&nbsp;to a <a href=\"http://www.genome.gov/glossary.cfm?key=gene\" target=\"_blank\">gene</a>&nbsp;located on the long (q) arm of <a href=\"http://ghr.nlm.nih.gov/chromosome=11#ideogram\" target=\"_blank\">chromosome 11</a>.[692] <br />\r\n<br />\r\nSome of the&nbsp;activating factors include [692]: <br />\r\n<br />\r\n&bull; Drugs (e.g., barbiturates,&nbsp;aluminum hydroxide,&nbsp;tricyclic antidepressants, alcohol)&nbsp;<br />\r\n&bull; Smoking <br />\r\n&bull; Surgery <br />\r\n&bull; Metabolic abnormalities such as low levels of sodium (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000394.htm\" target=\"_blank\">hyponatremia</a>)","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":692,"authors":"Koyamangalath K","articleTitle":"","bookWebsiteJournalTitle":"Medscape Reference","date":"April 28, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/205314-overview","dateAccessed":"2015-11-12T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1156,"questionText":"How is Chester porphyria inherited?","answerText":"Although the gene that causes Chester porphyria has not been identified, the condition is believed to be inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant </a>manner.[692]","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":692,"authors":"Koyamangalath K","articleTitle":"","bookWebsiteJournalTitle":"Medscape Reference","date":"April 28, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/205314-overview","dateAccessed":"2015-11-12T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1157,"questionText":"How might Chester porphyria be treated?","answerText":"The goal of management is to avoid&nbsp;activating factors. Treatment is symptomatic.[692]","dateModified":"2015-11-12T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":692,"authors":"Koyamangalath K","articleTitle":"","bookWebsiteJournalTitle":"Medscape Reference","date":"April 28, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/205314-overview","dateAccessed":"2015-11-12T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13419,"phenoTypeName":"Abdominal pain","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13714,"phenoTypeName":"Abnormal enzyme/coenzyme activity","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14474,"phenoTypeName":"Elevated urinary delta-aminolevulinic acid","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6266,"phenoTypeName":"Increased urinary porphobilinogen","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11012,"phenoTypeName":"Porphyrinuria","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5594,"phenoTypeName":"Back pain","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13409,"phenoTypeName":"Constipation","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":12141,"phenoTypeName":"Cranial nerve paralysis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6027,"phenoTypeName":"Hypertension","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":461,"phenoTypeName":"Limb pain","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8727,"phenoTypeName":"Mental deterioration","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13403,"phenoTypeName":"Nausea and vomiting","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":2357,"phenoTypeName":"Neck pain","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10015,"phenoTypeName":"Renal insufficiency","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8983,"phenoTypeName":"Tachycardia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10959,"phenoTypeName":"Abdominal distention","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14132,"phenoTypeName":"Anxiety","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11558,"phenoTypeName":"Brain imaging abnormality","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9380,"phenoTypeName":"Confusion","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13957,"phenoTypeName":"Dark urine","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6011,"phenoTypeName":"Depressivity","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13401,"phenoTypeName":"Diarrhea","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5216,"phenoTypeName":"Distal muscle weakness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8704,"phenoTypeName":"Excessive daytime somnolence","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13043,"phenoTypeName":"Fever","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14131,"phenoTypeName":"Hallucinations","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5694,"phenoTypeName":"Hepatocellular carcinoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4310,"phenoTypeName":"Hyponatremia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13771,"phenoTypeName":"Ileus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1855,"phenoTypeName":"Insomnia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11437,"phenoTypeName":"Memory impairment","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4476,"phenoTypeName":"Motor axonal neuropathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8509,"phenoTypeName":"Motor polyneuropathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13268,"phenoTypeName":"Paranoia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3452,"phenoTypeName":"Proximal muscle weakness in lower limbs","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3453,"phenoTypeName":"Proximal muscle weakness in upper limbs","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4485,"phenoTypeName":"Pseudobulbar paralysis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13725,"phenoTypeName":"Respiratory insufficiency","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8073,"phenoTypeName":"Respiratory paralysis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6008,"phenoTypeName":"Restlessness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13594,"phenoTypeName":"Sensory impairment","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8702,"phenoTypeName":"Coma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":11698,"phenoTypeName":"Dysuria","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8263,"phenoTypeName":"Hyperhidrosis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9423,"phenoTypeName":"Tremor","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6356,"phenoTypeName":"Urinary incontinence","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6442,"phenoTypeName":"Urinary retention","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13599,"phenoTypeName":"Acute episodes of neuropathic symptoms","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":9419,"phenoTypeName":"Muscle weakness","percentRanges":"-"},{"phenoTypeId":13408,"phenoTypeName":"Nausea","percentRanges":"-"},{"phenoTypeId":14323,"phenoTypeName":"Paralytic ileus","percentRanges":"-"},{"phenoTypeId":5592,"phenoTypeName":"Paresthesia","percentRanges":"-"},{"phenoTypeId":6018,"phenoTypeName":"Psychotic episodes","percentRanges":"-"},{"phenoTypeId":13400,"phenoTypeName":"Vomiting","percentRanges":"-"}],"medicalProducts":[{"productId":3,"genericName":"Hemin","tradeName":"Panhematin","tradeLink":"https://www.aiporphyria.com/","manufacturer":"","sponsor":"Abbott Laboratories","indication":"Amelioration of recurrent attacks of acute intermittent porphyria (AIP) temporarily related to the menstrual cycle in susceptible women and similar symptoms which occur in other patients with AIP, porphyria variegata and hereditary coproporphyria.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/panhematin","medlinePlusLink":""}],"EncodedName":"Acute_intermittent_porphyria"}